Shield Therapeutics plc Cash Flow Quality Index
Shield Therapeutics plc cash flow quality index. Shield Therapeutics plc (STX) has a Cash Flow Quality Index of 0.77x as of June 2020. Operating cash flow of GBX2.40 Million is below net income of GBX3.12 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Shield Therapeutics plc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shield Therapeutics plc Cash Flow Quality Index by Year (None–None)
Shield Therapeutics plc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Shield Therapeutics plc. For the full cash flow conversion analysis, see how efficiently does Shield Therapeutics plc generate cash.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|